HTATIP2 and cancer: It has been suggested that high expression of TIP30 might be associated with a prolonged RFS and DFS for cancer patients (random model HR = 0.49, 95%CI: 0.37–0.66), but some heterogeneity was detected among the studies (Chi2 = 9.15, df = 5, p = 0.10, I2 = 45%) (Fig 4).